Literature DB >> 1393275

Pituitary adenylate cyclase activating polypeptides, PACAP-27 and PACAP-38: stimulators of electrogenic ion secretion in the rat small intestine.

H M Cox1.   

Abstract

1. The effects of pituitary adenylate cyclase activating polypeptide (PACAP)-27 and PACAP-38 were investigated and compared with vasoactive intestinal polypeptide (VIP) responses in voltage clamped preparations of rat jejunum. Under these conditions electrogenic ion secretion was continuously recorded. 2. PACAP-27 is the most potent secretagogue described thus far, exhibiting a concentration-dependent dual secretory action. At low concentrations it stimulated rapid, transient secretory responses (not seen with either PACAP-38 or VIP) and these were inhibited by tetrodotoxin (TTX). At higher nM concentrations of PACAP-27 more prolonged secretory responses predominated which were insensitive to TTX. 3. In the presence of TTX, the concentration-response curve to PACAP-27 gave an EC50 value of 29.4 +/- 5.4 nM (n = 4) compared with 0.8 +/- 0.1 nM (n = 9) for PACAP-27 alone and 30.6 +/- 5.6 nM (n = 5) for PACAP-38. C-terminal fragments of PACAP-38 were not significantly effective. 4. Blockade of muscarinic and nicotinic receptors partially inhibited the low concentration effects of PACAP-27. Substance P desensitization and capsaicin pretreatment were effective at inhibiting the transient secretory PACAP-27 responses. Evidence is presented for selective, high affinity PACAP-27 receptors on submucous neurones innervating the mucosal region of the rat jejunum.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1393275      PMCID: PMC1907516          DOI: 10.1111/j.1476-5381.1992.tb14363.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  21 in total

1.  Molecular cloning and characterization of cDNA for the precursor of rat pituitary adenylate cyclase activating polypeptide (PACAP).

Authors:  K Ogi; C Kimura; H Onda; A Arimura; M Fujino
Journal:  Biochem Biophys Res Commun       Date:  1990-12-31       Impact factor: 3.575

2.  Projections of peptide-containing neurons in rat small intestine.

Authors:  E Ekblad; C Winther; R Ekman; R Håkanson; F Sundler
Journal:  Neuroscience       Date:  1987-01       Impact factor: 3.590

3.  Demonstration of specific binding sites for pituitary adenylate cyclase activating polypeptide (PACAP) in rat astrocytes.

Authors:  I Tatsuno; P E Gottschall; K Köves; A Arimura
Journal:  Biochem Biophys Res Commun       Date:  1990-05-16       Impact factor: 3.575

4.  Isolation of a neuropeptide corresponding to the N-terminal 27 residues of the pituitary adenylate cyclase activating polypeptide with 38 residues (PACAP38).

Authors:  A Miyata; L Jiang; R D Dahl; C Kitada; K Kubo; M Fujino; N Minamino; A Arimura
Journal:  Biochem Biophys Res Commun       Date:  1990-07-31       Impact factor: 3.575

5.  Effect of pituitary adenylate cyclase activating polypeptide on rat pancreatic exocrine secretion.

Authors:  Z Mungan; A Ertan; R A Hammer; A Arimura
Journal:  Peptides       Date:  1991 May-Jun       Impact factor: 3.750

6.  Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells.

Authors:  A Miyata; A Arimura; R R Dahl; N Minamino; A Uehara; L Jiang; M D Culler; D H Coy
Journal:  Biochem Biophys Res Commun       Date:  1989-10-16       Impact factor: 3.575

7.  Endogenous acetylcholine release and labelled acetylcholine formation from [3H]choline in the myenteric plexus of the guinea-pig ileum.

Authors:  J C Szerb
Journal:  Can J Physiol Pharmacol       Date:  1975-08       Impact factor: 2.273

8.  Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.

Authors:  V Le Meuth; N Farjaudon; W Bawab; E Chastre; G Rosselin; P Guilloteau; C Gespach
Journal:  Am J Physiol       Date:  1991-02

9.  Preferential binding of vasoactive intestinal polypeptide to basolateral membrane of rat and rabbit enterocytes.

Authors:  K Dharmsathaphorn; V Harms; D J Yamashiro; R J Hughes; H J Binder; E M Wright
Journal:  J Clin Invest       Date:  1983-01       Impact factor: 14.808

10.  Evidence that substance P is a neurotransmitter in the myenteric plexus.

Authors:  K Morita; R A North; Y Katayama
Journal:  Nature       Date:  1980-09-11       Impact factor: 49.962

View more
  5 in total

1.  Changes in pituitary adenylate cyclase-activating Peptide 27-like immunoreactive nervous structures in the porcine descending colon during selected pathological processes.

Authors:  Sławomir Gonkowski; Jarosław Całka
Journal:  J Mol Neurosci       Date:  2012-06-17       Impact factor: 3.444

2.  Molecular cloning and functional expression of the pituitary adenylate cyclase-activating polypeptide type I receptor.

Authors:  J R Pisegna; S A Wank
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-01       Impact factor: 11.205

3.  PACAP27 prevents Parkinson-like neuronal loss and motor deficits but not microglia activation induced by prostaglandin J2.

Authors:  Kai-Yvonne Shivers; Anastasia Nikolopoulou; Saima Ishaq Machlovi; Shankar Vallabhajosula; Maria E Figueiredo-Pereira
Journal:  Biochim Biophys Acta       Date:  2014-06-23

4.  Role of PACAP1 receptor in regulation of ECL cells and gastric acid secretion by pituitary adenylate cyclase activating peptide.

Authors:  J R Pisegna; G V Ohning; C Athmann; N Zeng; J H Walsh; G Sachs
Journal:  Ann N Y Acad Sci       Date:  2000       Impact factor: 5.691

5.  The pituitary adenylate cyclase activating polypeptide type 1 receptor (PAC1-R) is expressed on gastric ECL cells: evidence by immunocytochemistry and RT-PCR.

Authors:  N Zeng; T Kang; R M Lyu; H Wong; Y Wen; J H Walsh; G Sachs; J R Pisegna
Journal:  Ann N Y Acad Sci       Date:  1998-12-11       Impact factor: 5.691

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.